These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23430728)

  • 21. Improved dissolution of oleanolic acid with ternary solid dispersions.
    Liu L; Wang X
    AAPS PharmSciTech; 2007 Dec; 8(4):E113. PubMed ID: 18181534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theophylline particle design using chitosan by the spray drying.
    Asada M; Takahashi H; Okamoto H; Tanino H; Danjo K
    Int J Pharm; 2004 Feb; 270(1-2):167-74. PubMed ID: 14726132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.
    Hirlekar R; Kadam V
    AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Hanefeld A; Fischbach M; Maio M; Tan RB
    J Pharm Sci; 2011 Jul; 100(7):2876-85. PubMed ID: 21290385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid dispersion prepared by continuous cogrinding in an air jet mill.
    Muehlenfeld C; Kann B; Windbergs M; Thommes M
    J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder.
    Wang L; Cui FD; Hayase T; Sunada H
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1240-5. PubMed ID: 16204977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process.
    Kommavarapu P; Maruthapillai A; Palanisamy K; Koya RT
    Pak J Pharm Sci; 2016 Nov; 29(6):2023-2031. PubMed ID: 28375119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of colloidal solid dispersions: physiochemical considerations and in vitro release profile.
    Patel VI; Dave RH
    AAPS PharmSciTech; 2013 Jun; 14(2):620-8. PubMed ID: 23494469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triboelectrification and dissolution property enhancements of solid dispersions.
    Asare-Addo K; Šupuk E; Al-Hamidi H; Owusu-Ware S; Nokhodchi A; Conway BR
    Int J Pharm; 2015 May; 485(1-2):306-16. PubMed ID: 25772415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
    Al-Hamidi H; Obeidat WM; Nokhodchi A
    Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug.
    Gupta V; Gupta M; Madan AK
    PDA J Pharm Sci Technol; 2009; 63(1):58-70. PubMed ID: 19455942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.